Sign Up Today and Learn More About Upstream Bio Stock
Invest in or calculate the value of your shares in Upstream Bio or other pre-IPO companies through EquityZen's platform.
Upstream Bio Stock (UPBI)
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
About Upstream Bio Stock
Founded
2004
Headquarters
Waltham, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Upstream Bio Press Mentions
Stay in the know about the latest news on Upstream Bio
Upstream Bio prices IPO at $17 per share
seekingalpha • Oct 11, 2024
Upstream Bio raises $255 mln in US IPO
tradingview • Oct 11, 2024
Upstream Bio Announces Pricing of Upsized Initial Public Offering
tradingview • Oct 11, 2024
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs
seekingalpha • Oct 09, 2024
Upstream Bio goes public amid spate of IPOs
thepharmaletter • Sep 19, 2024
Upstream Bio Management
Leadership team at Upstream Bio
Chairman
Ron Renaud
Chief Executive Officer
Samantha Truex
Join now and verify your accreditation status to gain access to:
- Upstream Bio current valuation
- Upstream Bio stock price
- Available deals in Upstream Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Upstream Bio Stock
How to invest in Upstream Bio stock?
Accredited investors can buy pre-IPO stock in companies like Upstream Bio through EquityZen funds. These investments are made available by existing Upstream Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Upstream Bio stock?
Shareholders can sell their Upstream Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
